4.7 Article

Improving biological removal of pharmaceutical active compounds and estrogenic activity in a mesophilic anaerobic osmotic membrane bioreactor treating municipal sewage

Journal

CHEMOSPHERE
Volume 301, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.chemosphere.2022.134716

Keywords

Micropollutants; Wastewater treatment; Biosorption; Biodegradation; YES assay; Risk assessment

Funding

  1. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Brazilian National Council for Scientific and Technological Development)
  2. Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (Coordination of Improvement of Higher Level Personnel)
  3. Fundacao de Amparo a~Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas Gerais State Research Support Foundation)

Ask authors/readers for more resources

This study evaluated the performance of anaerobic osmotic MBR coupled with membrane distillation (OMBR-MD) in treating municipal sewage containing pharmaceuticals and estrogenic activity. The results showed that this system effectively removed pharmaceuticals and estrogenic activity, significantly reducing environmental and human health risks.
The contamination of water sources by pharmaceutically active compounds (PhACs) and their effect on aquatic communities and human health have become an environmental concern worldwide. Membrane bioreactors (MBRs) are an alternative to improve biological removal of recalcitrant organic compounds from municipal sewage. Their efficiency can be increased by using high retention membranes such as forward osmosis (FO) and membrane distillation (MD). Thus, this research aimed to evaluate the performance of an anaerobic osmotic MBR coupled with MD (OMBR-MD) in the treatment of municipal sewage containing PhACs and estrogenic activity. A submerged hybrid FO-MD module was integrated into the bioreactor. PhACs removal was higher than 96% due to biological degradation, biosorption and membrane retention. Biological removal of the PhACs was affected by the salinity build-up in the bioreactor, with reduction in biodegradation after 32 d. However, salinity increment had little or no effect on biosorption removal. The anaerobic OMBR-MD removed >99.9% of estrogenic activity, resulting in a distillate with 0.14 ng L-1 E2-eq, after 22 d, and 0.04 ng L-1 E2-eq, after 32 d. OMBR-MD treatment promoted reduction in environmental and human health risks from high to low, except for ketoprofen, which led to medium acute environmental and human health risks. Carcinogenic risks were reduced from unacceptable to negligible, regarding estrogenic activity. Thus, the hybrid anaerobic OMBR-MD demonstrated strong performance in reducing risks, even when human health is considered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available